Trifluoperazine and neuroleptic malignant syndrome Patient Reports February 12, 2012

Trifluoperazine Side Effects Report #5258869-7
Trifluoperazine side effect was reported by a Pharmacist from UNITED STATES on Mar 06, 2007. Female patient, 55 years of age, was diagnosed with bipolar disorder  and was treated with Trifluoperazine. After drug was administered, patient experienced the following side effects: neuroleptic malignant syndrome. Trifluoperazine dosage: 30 MG AT BEDTIME PO. During the same period patient was treated with PAROXETINE, CLONAZEPAM. Patient was hospitalized. Patient recovered.